# Usio, Inc.: financial statements, quarterly

USIO · Nasdaq · CIK 1088034 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/usio.md) · [Financials](/companies/usio/financials.md) · [Filings](/companies/usio/filings.md) · [Insiders](/companies/usio/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/usio/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [21.0](/filings/0001437749-24-033606.md) | [20.1 d](/filings/0001437749-25-009368.md) | [21.0](/filings/0001437749-25-016823.md) | [20.1](/filings/0001437749-25-025067.md) | [21.3](/filings/0001437749-25-034425.md) | [20.6 d](/filings/0001437749-26-008833.md) | [22.0](/filings/0001437749-26-016710.md) | [20.0](/filings/0001437749-26-027300.md) | [21.2](/filings/0001437749-25-034425.md) | [22.2 d](/filings/0001437749-26-008833.md) | [25.5](/filings/0001437749-26-016710.md) | [23.7](/filings/0001437749-26-027300.md) |
| Cost of revenue | $m | [16.3](/filings/0001437749-24-033606.md) | [14.9 d](/filings/0001437749-25-009368.md) | [16.1](/filings/0001437749-25-016823.md) | [15.3](/filings/0001437749-25-025067.md) | [16.4](/filings/0001437749-25-034425.md) | [15.5 d](/filings/0001437749-26-008833.md) | [17.2](/filings/0001437749-26-016710.md) | [14.8](/filings/0001437749-26-027300.md) | [16.3](/filings/0001437749-25-034425.md) | [17.4 d](/filings/0001437749-26-008833.md) | [20.3](/filings/0001437749-26-016710.md) | [18.0](/filings/0001437749-26-027300.md) |
| Gross profit | $m | [4.7](/filings/0001437749-24-033606.md) | [5.3 d](/filings/0001437749-25-009368.md) | [4.9](/filings/0001437749-25-016823.md) | [4.8](/filings/0001437749-25-025067.md) | [4.9](/filings/0001437749-25-034425.md) | [5.1 d](/filings/0001437749-26-008833.md) | [4.8](/filings/0001437749-26-016710.md) | [5.1](/filings/0001437749-26-027300.md) | [4.9](/filings/0001437749-25-034425.md) | [4.9 d](/filings/0001437749-26-008833.md) | [5.1](/filings/0001437749-26-016710.md) | [5.7](/filings/0001437749-26-027300.md) |
| Selling, general and administrative | $m | [5.4](/filings/0001437749-24-033606.md) | not reported | [5.1](/filings/0001437749-25-016823.md) | [4.0](/filings/0001437749-25-025067.md) | [4.1](/filings/0001437749-25-034425.md) | [4.5 d](/filings/0001437749-26-008833.md) | [4.1](/filings/0001437749-26-016710.md) | [4.6](/filings/0001437749-26-027300.md) | [4.5](/filings/0001437749-25-034425.md) | [5.1 d](/filings/0001437749-26-008833.md) | [4.4](/filings/0001437749-26-016710.md) | [4.6](/filings/0001437749-26-027300.md) |
| Operating income | $m | [(0.8)](/filings/0001437749-24-033606.md) | [(0.0) d](/filings/0001437749-25-009368.md) | [(0.3)](/filings/0001437749-25-016823.md) | [(0.2)](/filings/0001437749-25-025067.md) | [(0.4)](/filings/0001437749-25-034425.md) | [(0.6) d](/filings/0001437749-26-008833.md) | [(0.2)](/filings/0001437749-26-016710.md) | [(0.4)](/filings/0001437749-26-027300.md) | [(0.5)](/filings/0001437749-25-034425.md) | [(1.3) d](/filings/0001437749-26-008833.md) | [0.2](/filings/0001437749-26-016710.md) | [0.4](/filings/0001437749-26-027300.md) |
| Interest expense | $m | [0.0](/filings/0001437749-23-030950.md) | [0.0 d](/filings/0001437749-24-009583.md) | [0.0](/filings/0001437749-24-017056.md) | [0.0](/filings/0001437749-25-025067.md) | [0.0](/filings/0001437749-25-034425.md) | [0.0 d](/filings/0001437749-26-008833.md) | [0.0](/filings/0001437749-26-016710.md) | [0.0](/filings/0001437749-26-027300.md) | [0.0](/filings/0001437749-25-034425.md) | [0.0 d](/filings/0001437749-26-008833.md) | [0.0](/filings/0001437749-26-016710.md) | [0.0](/filings/0001437749-26-027300.md) |
| Income tax | $m | [0.1](/filings/0001437749-24-033606.md) | [0.1 d](/filings/0001437749-25-009368.md) | [0.1](/filings/0001437749-25-016823.md) | [0.1](/filings/0001437749-25-025067.md) | [(3.1)](/filings/0001437749-25-034425.md) | [0.3 d](/filings/0001437749-26-008833.md) | [0.1](/filings/0001437749-26-016710.md) | [0.1](/filings/0001437749-26-027300.md) | [0.1](/filings/0001437749-25-034425.md) | [0.3 d](/filings/0001437749-26-008833.md) | [0.2](/filings/0001437749-26-016710.md) | [0.2](/filings/0001437749-26-027300.md) |
| Net income | $m | [(0.7)](/filings/0001437749-24-033606.md) | [0.0 d](/filings/0001437749-25-009368.md) | [(0.3)](/filings/0001437749-25-034425.md) | [0.1](/filings/0001437749-25-034425.md) | [2.9](/filings/0001437749-25-034425.md) | [0.6 d](/filings/0001437749-26-008833.md) | [(0.2)](/filings/0001437749-26-027300.md) | [(0.4)](/filings/0001437749-26-027300.md) | [(0.4)](/filings/0001437749-25-034425.md) | [(1.5) d](/filings/0001437749-26-008833.md) | [0.1](/filings/0001437749-26-027300.md) | [0.3](/filings/0001437749-26-027300.md) |
| Diluted EPS | $ per share | [(0.03)](/filings/0001437749-24-033606.md) | not reported | [(0.01)](/filings/0001437749-25-016823.md) | [0.00](/filings/0001437749-25-025067.md) | [0.10](/filings/0001437749-25-034425.md) | not reported | [(0.01)](/filings/0001437749-26-016710.md) | [(0.01)](/filings/0001437749-26-027300.md) | [(0.02)](/filings/0001437749-25-034425.md) | not reported | [0.00](/filings/0001437749-26-016710.md) | [0.01](/filings/0001437749-26-027300.md) |
| Basic EPS | $ per share | [(0.03)](/filings/0001437749-24-033606.md) | not reported | [(0.01)](/filings/0001437749-25-016823.md) | [0.00](/filings/0001437749-25-025067.md) | [0.10](/filings/0001437749-25-034425.md) | not reported | [(0.01)](/filings/0001437749-26-016710.md) | [(0.01)](/filings/0001437749-26-027300.md) | [(0.02)](/filings/0001437749-25-034425.md) | not reported | [0.00](/filings/0001437749-26-016710.md) | [0.01](/filings/0001437749-26-027300.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [7.4](/filings/0001437749-24-033606.md) | [7.2](/filings/0001437749-26-008833.md) | [7.1](/filings/0001437749-25-025067.md) | [7.2](/filings/0001437749-25-034425.md) | [8.4](/filings/0001437749-25-034425.md) | [8.1](/filings/0001437749-26-027300.md) | [8.7](/filings/0001437749-26-016710.md) | [7.5](/filings/0001437749-26-027300.md) | [7.7](/filings/0001437749-25-034425.md) | [7.4](/filings/0001437749-26-027300.md) | [7.7](/filings/0001437749-26-016710.md) | [6.4](/filings/0001437749-26-027300.md) |
| Current assets | $m | [121](/filings/0001437749-23-030950.md) | [97.2](/filings/0001437749-25-009368.md) | [89.9](/filings/0001437749-24-017056.md) | [100](/filings/0001437749-24-026782.md) | [102](/filings/0001437749-24-033606.md) | [95.2](/filings/0001437749-26-008833.md) | [97.9](/filings/0001437749-25-016823.md) | [96.8](/filings/0001437749-25-025067.md) | [88.1](/filings/0001437749-25-034425.md) | [123](/filings/0001437749-26-027300.md) | [107](/filings/0001437749-26-016710.md) | [111](/filings/0001437749-26-027300.md) |
| Total assets | $m | [131](/filings/0001437749-23-030950.md) | [107](/filings/0001437749-25-009368.md) | [99.1](/filings/0001437749-24-017056.md) | [109](/filings/0001437749-24-026782.md) | [115](/filings/0001437749-24-033606.md) | [107](/filings/0001437749-26-008833.md) | [110](/filings/0001437749-25-016823.md) | [108](/filings/0001437749-25-025067.md) | [99.4](/filings/0001437749-25-034425.md) | [135](/filings/0001437749-26-027300.md) | [120](/filings/0001437749-26-016710.md) | [124](/filings/0001437749-26-027300.md) |
| Current liabilities | $m | [114](/filings/0001437749-23-030950.md) | [89.2](/filings/0001437749-25-009368.md) | [81.2](/filings/0001437749-24-017056.md) | [90.7](/filings/0001437749-24-026782.md) | [92.5](/filings/0001437749-24-033606.md) | [84.9](/filings/0001437749-26-008833.md) | [87.7](/filings/0001437749-25-016823.md) | [86.9](/filings/0001437749-25-025067.md) | [78.1](/filings/0001437749-25-034425.md) | [114](/filings/0001437749-26-027300.md) | [98.3](/filings/0001437749-26-016710.md) | [101](/filings/0001437749-26-027300.md) |
| Total liabilities | $m | [116](/filings/0001437749-23-030950.md) | [91.9](/filings/0001437749-25-009368.md) | [83.8](/filings/0001437749-24-017056.md) | [93.1](/filings/0001437749-24-026782.md) | [95.7](/filings/0001437749-24-033606.md) | [88.1](/filings/0001437749-26-008833.md) | [90.6](/filings/0001437749-25-016823.md) | [89.6](/filings/0001437749-25-025067.md) | [80.7](/filings/0001437749-25-034425.md) | [117](/filings/0001437749-26-027300.md) | [102](/filings/0001437749-26-016710.md) | [105](/filings/0001437749-26-027300.md) |
| Long-term debt | $m | [0.0](/filings/0001437749-23-030950.md) | [0.7](/filings/0001437749-25-009368.md) | [0.6](/filings/0001437749-24-017056.md) | [0.6](/filings/0001437749-24-026782.md) | [0.6](/filings/0001437749-24-033606.md) | [0.6](/filings/0001437749-26-008833.md) | [0.5](/filings/0001437749-25-016823.md) | [0.5](/filings/0001437749-25-025067.md) | [0.6](/filings/0001437749-25-034425.md) | [1.1](/filings/0001437749-26-027300.md) | [1.0](/filings/0001437749-26-016710.md) | [0.9](/filings/0001437749-26-027300.md) |
| Current portion of debt | $m | [0.0](/filings/0001437749-23-030950.md) | [0.1](/filings/0001437749-25-009368.md) | [0.2](/filings/0001437749-24-017056.md) | [0.2](/filings/0001437749-24-026782.md) | [0.2](/filings/0001437749-24-033606.md) | [0.1](/filings/0001437749-26-008833.md) | [0.2](/filings/0001437749-25-016823.md) | [0.2](/filings/0001437749-25-025067.md) | [0.2](/filings/0001437749-25-034425.md) | [0.3](/filings/0001437749-26-027300.md) | [0.3](/filings/0001437749-26-016710.md) | [0.3](/filings/0001437749-26-027300.md) |
| Shareholders' equity | $m | [14.9](/filings/0001437749-24-033606.md) | [15.1](/filings/0001437749-26-008833.md) | [15.3](/filings/0001437749-25-034425.md) | [15.7](/filings/0001437749-25-034425.md) | [18.9](/filings/0001437749-25-034425.md) | [19.2](/filings/0001437749-26-027300.md) | [19.0](/filings/0001437749-26-027300.md) | [18.7](/filings/0001437749-26-027300.md) | [18.7](/filings/0001437749-25-034425.md) | [17.9](/filings/0001437749-26-027300.md) | [18.1](/filings/0001437749-26-027300.md) | [18.8](/filings/0001437749-26-027300.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [13.7 d](/filings/0001437749-24-033606.md) | [(38.0) d](/filings/0001437749-25-009368.md) | [0.1](/filings/0001437749-25-016823.md) | [0.4 d](/filings/0001437749-25-025067.md) | [1.4 d](/filings/0001437749-25-034425.md) | [1.0 d](/filings/0001437749-26-008833.md) | [1.4](/filings/0001437749-26-016710.md) | [(0.3) d](/filings/0001437749-26-027300.md) | [0.3 d](/filings/0001437749-25-034425.md) | [0.1 d](/filings/0001437749-26-008833.md) | [0.9](/filings/0001437749-26-016710.md) | [(0.7) d](/filings/0001437749-26-027300.md) |
| Capital expenditure | $m | [0.2 d](/filings/0001437749-24-033606.md) | [0.2 d](/filings/0001437749-25-009368.md) | [0.2](/filings/0001437749-25-016823.md) | [(0.1) d](/filings/0001437749-25-025067.md) | [0.1 d](/filings/0001437749-25-034425.md) | [0.1 d](/filings/0001437749-26-008833.md) | [0.0](/filings/0001437749-26-016710.md) | [0.1 d](/filings/0001437749-26-027300.md) | [0.2 d](/filings/0001437749-25-034425.md) | [0.1 d](/filings/0001437749-26-008833.md) | [0.4](/filings/0001437749-26-016710.md) | [0.1 d](/filings/0001437749-26-027300.md) |
| Share repurchases | $m | [0.0 d](/filings/0001437749-24-033606.md) | [0.4 d](/filings/0001437749-25-009368.md) | [0.0](/filings/0001437749-25-016823.md) | [0.1 d](/filings/0001437749-25-025067.md) | [0.2 d](/filings/0001437749-25-034425.md) | [1.0 d](/filings/0001437749-26-008833.md) | [0.4](/filings/0001437749-26-016710.md) | [0.4 d](/filings/0001437749-26-027300.md) | [0.1 d](/filings/0001437749-25-034425.md) | [0.3 d](/filings/0001437749-26-008833.md) | [0.2](/filings/0001437749-26-016710.md) | [0.1 d](/filings/0001437749-26-027300.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [20.4](/filings/0001437749-23-030950.md) | [27.5](/filings/0001437749-24-017056.md) | [26.4](/filings/0001437749-24-026782.md) | [26.4](/filings/0001437749-24-033606.md) | [26.4](/filings/0001437749-25-016823.md) | [26.5](/filings/0001437749-25-025067.md) | [27.3](/filings/0001437749-25-034425.md) | [26.6](/filings/0001437749-26-016710.md) | [26.5](/filings/0001437749-26-027300.md) | [26.9](/filings/0001437749-25-034425.md) | [27.7](/filings/0001437749-26-016710.md) | [27.8](/filings/0001437749-26-027300.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 28,495,414 at 2026-08-10, from the cover of the [10-Q filed 2026-08-12](/filings/0001437749-26-027300.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:33 ET. No prices; not investment advice.